Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGrainger plc Regulatory News (GRI)

Share Price Information for Grainger plc (GRI)

Share Price is delayed by 15 minutes
Get Live Data
150.40    -2.20 (-1.44%)
Bid:
150.90
Ask:
151.10
Spread: 0.20 (0.133%)
Market Cap: £1.11b
GRI Live PriceLast checked at - London Stock Exchange

Intraday Grainger plc Share Chart

Statement re Possible Offer

29 Mar 2010 16:52

RNS Number : 3703J
Grainger PLC
29 March 2010
 



NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN OR INTO THE UNITED STATES, CANADA, AUSTRALIA, JAPAN OR ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OF SUCH JURISDICTION

29 March 2010

 

Grainger plc ("Grainger") - Statement re possible offer for Sovereign Reversions plc ("Sovereign Reversions")

Grainger notes the announcement by Sovereign Reversions earlier today and confirms that it has made a preliminary approach to the Board of Sovereign Reversions with a view to entering into discussions about a possible offer for Sovereign Reversions. Grainger currently envisages making an offer at 185p in cash per Sovereign Reversions share. An offer at this level would represent a premium of 51% to the Sovereign Reversions closing price on 26 March 2010 (the last business day prior to the announcement by Sovereign Reversions of a possible offer approach).

Grainger would like to emphasize that there can be no certainty that an offer for Sovereign Reversions will be forthcoming. A further announcement will be made in due course if appropriate.

Pursuant to Rule 2.4 (c) of the Code, Grainger reserves the right to reduce the level of this possible offer if Sovereign Reversions pays a dividend or makes any other distribution to its shareholders in which case Grainger would make an equivalent reduction. Grainger also reserves the right to reduce the level of this possible offer with the recommendation of the Board of Sovereign Reversions. In addition, Grainger reserves the right to introduce other forms of consideration in substitution for all or part of the cash consideration.

This announcement does not constitute an announcement of a firm intention to make an offer under Rule 2.5 of The City Code on Takeovers and Mergers (the "Code").

 

Enquiries:

Grainger

Andrew Cunningham, Chief Executive

Dave Butler

 

Tel: +44 (0)20 7495 4700

 

J.P. Morgan Cazenove 

Robert Fowlds

Tel: +44 (0)20 7588 2828

Bronson Albery

 

Financial Dynamics

Stephanie Highett

Tel: +44 (0) 20 7831 3113

Dido Laurimore

 

The release, distribution or publication of this announcement in jurisdictions other than the UK may be restricted by law and therefore any persons who are subject to the laws of any jurisdiction other than the UK should inform themselves about and observe any applicable requirements.

J.P. Morgan plc, which conducts its UK investment banking businesses as J.P. Morgan Cazenove and is authorised and regulated in the United Kingdom by the FSA, is acting as financial adviser to Grainger and no-one else in connection with the contents of this announcement and will not be responsible to any person other than Grainger for providing the protections afforded to customers of J.P. Morgan plc nor for providing advice in relation to any matter referred to herein.

Dealing Disclosure Requirements

Under the provisions of Rule 8.3 of the Code, if any person is, or becomes, "interested" (directly or indirectly) in 1 per cent. or more of any class of "relevant securities" of Sovereign Reversions, all "dealings" in any "relevant securities" of that company (including by means of an option in respect of, or a derivative referenced to, any such "relevant securities") must be publicly disclosed by no later than 3:30pm (London time) on the London business day following the date of the relevant transaction. This requirement will continue until the date on which the offer becomes, or is declared, unconditional as to acceptances, lapses or is otherwise withdrawn or on which the "offer period" otherwise ends. If two or more persons act together pursuant to an agreement or understanding, whether formal or informal, to acquire an "interest" in "relevant securities" of Sovereign Reversions, they will be deemed to be a single person for the purpose of Rule 8.3.

Under the provisions of Rule 8.1 of the Code, all "dealings" in "relevant securities" of Sovereign Reversions by Grainger or Sovereign Reversions, or by any of their respective "associates", must be disclosed by no later than 12:00 noon (London time) on the London business day following the date of the relevant transaction.

A disclosure table, giving details of the companies in whose "relevant securities" "dealings" should be disclosed, and the number of such securities in issue, can be found on the Panel's website at www.thetakeoverpanel.org.uk.

"Interests in securities" arise, in summary, when a person has long economic exposure, whether conditional or absolute, to changes in the price of securities. In particular, a person will be treated as having an "interest" by virtue of the ownership or control of securities, or by virtue of any option in respect of, or derivative referenced to, securities.

Terms in quotation marks are defined in the Code, which can also be found on the Panel's website. If you are in any doubt as to whether or not you are required to disclose a "dealing" under Rule 8, you should consult the Panel.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
OFDEASDNASEEEFF
Date   Source Headline
19th May 201612:47 pmRNSDividend Declaration
19th May 20167:00 amRNSHalf year results for six months ended 31 March 16
4th May 201610:06 amRNSBlock listing Interim Review
4th May 201610:05 amRNSBlock listing Interim Review
14th Apr 20162:08 pmRNSHolding(s) in Company
14th Apr 201610:26 amRNSHolding(s) in Company
13th Apr 20169:00 amRNSNotice of Interim Results
13th Apr 20167:00 amRNSGrainger exits majority of German portfolio
5th Apr 201610:30 amRNSHolding(s) in Company
7th Mar 20164:29 pmRNSDirector/PDMR Shareholding
24th Feb 201612:20 pmRNSDirector/PDMR Shareholding
15th Feb 20164:16 pmRNSDirector/PDMR Shareholding
15th Feb 20164:13 pmRNSDirector/PDMR Shareholding
11th Feb 20163:09 pmRNSHolding(s) in Company
11th Feb 20167:00 amRNSTrading Update
10th Feb 20164:23 pmRNSAGM Statement
9th Feb 20167:00 amRNS£57.3M London PRS acquisition
5th Feb 20167:00 amRNSSale of German portfolio and business
2nd Feb 20163:29 pmRNSDirector/PDMR Shareholding
1st Feb 20163:16 pmRNSDirector/PDMR Shareholding
1st Feb 20167:00 amRNS£100M, 600 UNIT ACQUISITION ACCELERATES PRS GROWTH
28th Jan 20167:00 amRNSStrategy Update
26th Jan 201611:09 amRNSHolding(s) in Company
20th Jan 201611:05 amRNSDisclosure of Home Member State
15th Jan 20162:51 pmRNSDirector/PDMR Shareholding
15th Jan 20162:31 pmRNSDirector/PDMR Shareholding
13th Jan 20163:26 pmRNSDirector/PDMR Shareholding
5th Jan 201610:43 amRNSStrategy Presentation
4th Jan 20167:00 amRNSGrainger Sells Equity Release Division
8th Dec 201511:25 amRNSDirector/PDMR Shareholding
1st Dec 20154:31 pmRNSHolding(s) in Company
30th Nov 20153:48 pmRNSHolding(s) in Company
20th Nov 20155:20 pmRNSFinal Results - re-issued for ISE disclosure
19th Nov 20157:00 amRNSPreliminary Results for the year ended 30 Sep 2015
19th Nov 20157:00 amRNSGrainger Exits German JV
28th Oct 20157:00 amRNSGRAINGER ACQUIRES PRS PORTFOLIO FOR £10.4M
20th Oct 201511:27 amRNSBlocklisting Interim Review
20th Oct 201511:27 amRNSBlocklisting Interim Review
20th Oct 20157:00 amRNSDirectorate Change
7th Oct 20157:00 amRNSUpdate on Capital Structure
30th Sep 20159:00 amRNSNotice of Results
7th Sep 20153:29 pmRNSDirector/PDMR Shareholding
3rd Sep 20153:01 pmRNSHolding(s) in Company
2nd Sep 20154:37 pmRNSDirector/PDMR Shareholding
2nd Sep 20154:24 pmRNSDirectorate Change
13th Aug 20157:00 amRNSTrading Update
7th Aug 20157:00 amRNSGrainger renews syndicated bank facility
6th Aug 20159:40 amRNSNOTICE OF TRADING UPDATE
30th Jul 20154:30 pmRNSDirector/PDMR Shareholding
27th Jul 20154:12 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.